Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4017 in Idiopathic Intracranial Hypertension
NCT02017444Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Apr 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD4017 in idiopathic intracranial hypertension (IIH), sponsored by University of Birmingham. Started Apr 2014; status: completed.
02
Drugs
AZD4017
03
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on NCT02017444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017444.